title: Protective Effect of Pyrroloquinoline Quinone (PQQ) in Rat Model of Intracerebral Hemorrhage.
abstract: Pyrroloquinoline quinone (PQQ) has invoked considerable interest because of its presence in foods, antioxidant properties, cofactor of dehydrogenase, and amine oxidase. Protective roles of PQQ in central nervous system diseases, such as experimental stroke and spinal cord injury models have been emerged. However, it is unclear whether intracerebral hemorrhage (ICH), as an acute devastating disease, can also benefit from PQQ in experimental conditions. Herein, we examined the possible effect of PQQ on neuronal functions following ICH in the adult rats. The results showed that rats pretreated with PQQ at 10 mg/kg effectively improved the locomotor functions, alleviated the hematoma volumes, and reduced the expansion of brain edema after ICH. Also, pretreated rats with PQQ obviously reduced the production of reactive oxygen species after ICH, probably due to its antioxidant properties. Further, we found that, Bcl-2/Bax, the important indicator of oxidative stress insult in mitochondria after ICH, exhibited increasing ratio in PQQ-pretreated groups. Moreover, activated caspase-3, the apoptotic executor, showed coincident alleviation in PQQ groups after ICH. Collectively, we speculated that PQQ might be an effective and potential neuroprotectant in clinical therapy for ICH.
authors.affiliation: Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.|The Second People's Hospital of Nantong, Nantong, 226002, China.
authors.forename: Hongjian
authors.initials: H
authors.lastname: Lu
authors.affiliation: Department of Neurology, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, China.|Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College of Nantong University, Nantong, 226001, Jiangsu Province, China.
authors.forename: Jiabing
authors.initials: J
authors.lastname: Shen
authors.affiliation: The Second People's Hospital of Nantong, Nantong, 226002, China.
authors.forename: Xinjian
authors.initials: X
authors.lastname: Song
authors.affiliation: The Second People's Hospital of Nantong, Nantong, 226002, China.
authors.forename: Jianbin
authors.initials: J
authors.lastname: Ge
authors.affiliation: Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College of Nantong University, Nantong, 226001, Jiangsu Province, China.
authors.forename: Rixin
authors.initials: R
authors.lastname: Cai
authors.affiliation: Department of Neurology, Affiliated Hospital of Nantong University, Nantong, 226001, Jiangsu Province, China.|Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College of Nantong University, Nantong, 226001, Jiangsu Province, China.
authors.forename: Aihua
authors.initials: A
authors.lastname: Dai
authors.affiliation: Department of Rehabilitation Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China. jiangzh3721@163.com.
authors.forename: Zhongli
authors.initials: Z
authors.lastname: Jiang
mesh_terms: D000818:Animals; D002543:Cerebral Hemorrhage / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D004195:Disease Models, Animal; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D045542:PQQ Cofactor / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species; D045542:PQQ Cofactor
keywords: ICH; Neuroprotectant; PQQ; ROS; Rat
references.citation: J Neural Transm (Vienna). 2013 Sep;120 Suppl 1:S35-41
references.pmid: 23720189
references.citation: J Mol Neurosci. 2013 Sep;51(1):159-69
references.pmid: 23386121
references.citation: Stroke. 1995 Apr;26(4):627-34; discussion 635
references.pmid: 7709410
references.citation: Biochem Biophys Res Commun. 2009 Jan 9;378(2):308-12
references.pmid: 19026989
references.citation: Acta Neurochir Suppl. 2008;105:59-65
references.pmid: 19066084
references.citation: FEBS Lett. 1996 Sep 16;393(2-3):317-20
references.pmid: 8814312
references.citation: J Neurotrauma. 2012 Dec 10;29(18):2798-804
references.pmid: 22862734
references.citation: Regul Toxicol Pharmacol. 2013 Nov;67(2):189-97
references.pmid: 23891671
references.citation: Free Radic Res. 2009 Mar;43(3):224-33
references.pmid: 19191107
references.citation: Brain Res. 2006 Jun 13;1094(1):200-6
references.pmid: 16709402
references.citation: Can J Physiol Pharmacol. 2015 Jan;93(1):71-9
references.pmid: 25474723
references.citation: Neurosurg Clin N Am. 2002 Jul;13(3):371-83
references.pmid: 12486926
references.citation: Biosci Biotechnol Biochem. 1996 Jan;60(1):92-4
references.pmid: 8824828
references.citation: Eur J Pharmacol. 1997 May 12;326(1):67-74
references.pmid: 9178657
references.citation: Hiroshima J Med Sci. 1989 Mar;38(1):49-51
references.pmid: 2546903
references.citation: J Neurotrauma. 2012 Mar 20;29(5):851-64
references.pmid: 22040225
references.citation: Behav Brain Res. 2014 May 1;264:151-60
references.pmid: 24518201
references.citation: Mitochondrion. 2011 Jan;11(1):108-18
references.pmid: 20727424
references.citation: Biochem Biophys Res Commun. 2007 Nov 16;363(2):257-62
references.pmid: 17880922
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:214-23
references.pmid: 23123357
references.citation: Biol Pharm Bull. 2008 Jul;31(7):1321-6
references.pmid: 18591768
references.citation: J Neurosci. 2000 Mar 15;20(6):2409-17
references.pmid: 10704515
references.citation: Ann Neurol. 2007 Apr;61(4):352-62
references.pmid: 17457822
references.citation: Gen Physiol Biophys. 2013 Dec;32(4):489-504
references.pmid: 24067282
references.citation: J Biol Chem. 1997 Dec 12;272(50):31482-8
references.pmid: 9395483
references.citation: Life Sci. 1993;52(24):1909-15
references.pmid: 8389410
references.citation: N Engl J Med. 2013 Jun 20;368(25):2355-65
references.pmid: 23713578
references.citation: Brain Res. 2010 Nov 18;1361:133-9
references.pmid: 20850419
references.citation: Neurosci Lett. 1994 Feb 28;168(1-2):189-92
references.pmid: 7518062
references.citation: Pharmacol Biochem Behav. 2013 Mar;104:163-8
references.pmid: 23369986
references.citation: Biosci Biotechnol Biochem. 1993 Jul;57(7):1231-3
references.pmid: 7764070
references.citation: Acta Neurochir Suppl. 2008;105:43-6
references.pmid: 19066080
references.citation: J Cereb Blood Flow Metab. 2004 Oct;24(10):1133-45
references.pmid: 15529013
references.citation: Nature. 2003 Apr 24;422(6934):832
references.pmid: 12712191
references.citation: J Nutr. 2000 Apr;130(4):719-27
references.pmid: 10736320
references.citation: Alcohol Clin Exp Res. 2014 Jul;38(7):2127-37
references.pmid: 24930470
references.citation: Toxicol Appl Pharmacol. 2011 Apr 1;252(1):62-72
references.pmid: 21320517
references.citation: Int Immunopharmacol. 2014 Oct;22(2):522-5
references.pmid: 25000335
references.citation: Neurochem Res. 2007 Mar;32(3):489-95
references.pmid: 17268846
references.citation: J Clin Biochem Nutr. 2008 Jan;42:29-34
references.pmid: 18231627
references.citation: Stroke. 2009 Mar;40(3 Suppl):S92-4
references.pmid: 19064796
references.citation: Behav Brain Res. 2014 Jan 1;258:153-9
references.pmid: 24149067
references.citation: J Cereb Blood Flow Metab. 2014 Sep;34(9):1463-71
references.pmid: 24917041